David A. Khan

25.9k total citations · 5 hit papers
208 papers, 10.5k citations indexed

About

David A. Khan is a scholar working on Pharmacology, Immunology and Allergy and Physiology. According to data from OpenAlex, David A. Khan has authored 208 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pharmacology, 62 papers in Immunology and Allergy and 61 papers in Physiology. Recurrent topics in David A. Khan's work include Drug-Induced Adverse Reactions (71 papers), Asthma and respiratory diseases (58 papers) and Food Allergy and Anaphylaxis Research (46 papers). David A. Khan is often cited by papers focused on Drug-Induced Adverse Reactions (71 papers), Asthma and respiratory diseases (58 papers) and Food Allergy and Anaphylaxis Research (46 papers). David A. Khan collaborates with scholars based in United States, Canada and Italy. David A. Khan's co-authors include David M. Lang, Jay M. Portnoy, Richard A. Nicklas, Joann Blessing-Moore, E. Sherwood Brown, Dana Wallace, John Oppenheimer, David I. Bernstein, Diane E. Schuller and Sheldon L. Spector and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

David A. Khan

182 papers receiving 10.1k citations

Hit Papers

Allergen immunotherapy: A practice parameter third update 2008 2026 2014 2020 2010 2008 2014 2014 2022 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Khan United States 50 4.7k 3.4k 2.6k 2.6k 1.7k 208 10.5k
David M. Lang United States 46 4.7k 1.0× 3.5k 1.0× 1.6k 0.6× 2.3k 0.9× 1.2k 0.7× 153 9.0k
F. Estelle R. Simons Canada 67 9.2k 1.9× 6.1k 1.8× 2.5k 1.0× 2.6k 1.0× 1.6k 0.9× 224 14.4k
Gianenrico Senna Italy 40 4.2k 0.9× 2.9k 0.9× 1.2k 0.5× 1.6k 0.6× 762 0.5× 279 6.8k
Sheldon L. Spector United States 45 4.3k 0.9× 5.5k 1.6× 574 0.2× 2.0k 0.8× 1.6k 0.9× 140 10.2k
Leslie C. Grammer United States 53 4.3k 0.9× 4.1k 1.2× 833 0.3× 1.3k 0.5× 726 0.4× 338 10.0k
Luc S. De Clerck Belgium 45 2.5k 0.5× 1.3k 0.4× 1.6k 0.6× 1.1k 0.4× 1.6k 0.9× 229 6.7k
Thomas B. Casale United States 61 8.1k 1.7× 10.3k 3.1× 509 0.2× 2.8k 1.1× 2.2k 1.3× 447 15.8k
Michael Kaliner United States 62 4.1k 0.9× 6.1k 1.8× 1.2k 0.5× 810 0.3× 956 0.6× 347 12.8k
Joaquim Mullol Spain 60 7.4k 1.6× 7.0k 2.1× 780 0.3× 1.1k 0.4× 946 0.6× 400 14.3k
W. J. Stevens Belgium 45 2.3k 0.5× 1.2k 0.4× 1.0k 0.4× 1.2k 0.5× 783 0.5× 166 5.9k

Countries citing papers authored by David A. Khan

Since Specialization
Citations

This map shows the geographic impact of David A. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Khan more than expected).

Fields of papers citing papers by David A. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Khan. The network helps show where David A. Khan may publish in the future.

Co-authorship network of co-authors of David A. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Khan. A scholar is included among the top collaborators of David A. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Khan. David A. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, David A., et al.. (2025). Navigating the Uncommon: Gastric Perforation as a Complication of Granulomatosis With Polyangiitis. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5756–A5756.
3.
Alvarez, Kristin, et al.. (2025). Direct Amoxicillin Challenges for Penicillin Allergy Through Pediatric Primary Care Group Visits: A Pilot Study. Open Forum Infectious Diseases. 12(5). ofaf236–ofaf236.
4.
Ritz, Thomas, Juliet L. Kroll, David A. Khan, et al.. (2024). fMRI BOLD responses to film stimuli and their association with exhaled nitric oxide in asthma and health. Psychophysiology. 61(5). e14513–e14513.
5.
Assa’ad, Amal, et al.. (2024). Health disparities in the Middle East: Representative analysis of the region. SHILAP Revista de lepidopterología. 4(1). 100350–100350.
7.
Lees‐Murdock, Diane J., David A. Khan, Richard S. Irwin, et al.. (2024). Assessing the Efficacy of Active Learning to Support Student Performance Across Undergraduate Programmes in Biomedical Science. British Journal of Biomedical Science. 81. 12148–12148. 4 indexed citations
8.
Khan, David A., et al.. (2024). Severe Multiple Drug Intolerance Syndrome in Fibromyalgia and Irritable Bowel Syndrome. The Journal of Allergy and Clinical Immunology In Practice. 12(5). 1192–1201.
9.
Tanno, Luciana Kase, David A. Khan, James L. Sublett, et al.. (2023). Optimization of the allergen classification of the International Classification Of Diseases, 11th Revision (ICD-11). Journal of Allergy and Clinical Immunology. 151(6). 1655–1659.e3.
10.
Khan, David A., Elizabeth J. Phillips, Alexei Gonzalez‐Estrada, et al.. (2023). United States Drug Allergy Registry (USDAR) grading scale for immediate drug reactions. Journal of Allergy and Clinical Immunology. 152(6). 1581–1586. 13 indexed citations
11.
Jutel, Marek, Giselle Mosnaim, Jonathan A. Bernstein, et al.. (2023). The One Health approach for allergic diseases and asthma. Allergy. 78(7). 1777–1793. 16 indexed citations
12.
Joshi, Shyam & David A. Khan. (2018). Effective Use of Dupilumab in Managing Systemic Allergic Contact Dermatitis. Dermatitis. 29(5). 282–284. 40 indexed citations
14.
Khan, David A., et al.. (2017). Adverse Reactions to Biologic Therapy. Immunology and Allergy Clinics of North America. 37(2). 397–412. 54 indexed citations
15.
Khan, David A., et al.. (2014). Asthma and depression: the Cooper Center Longitudinal Study. Annals of Allergy Asthma & Immunology. 112(5). 432–436. 34 indexed citations
16.
Compalati, Enrico, et al.. (2010). Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system. Current Opinion in Allergy and Clinical Immunology. 10(4). 362–369. 46 indexed citations
17.
Khan, David A., Christopher Randolph, & Sheldon L. Spector. (2008). Allergy diagnostic testing: An updated practice parameter (Annals of Allergy, Asthma and Immunology (2008) 100, SUPPL. 3, (S1-S148)). Annals of Allergy Asthma & Immunology. 100(5). 35 indexed citations
18.
Brown, E. Sherwood, Michelle Murray, Thomas Carmody, et al.. (2008). The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder. Annals of Allergy Asthma & Immunology. 100(5). 433–438. 41 indexed citations
19.
Morgan, Matt & David A. Khan. (2008). Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Annals of Allergy Asthma & Immunology. 100(5). 403–412. 46 indexed citations
20.
Brown, E. Sherwood, et al.. (2000). Psychiatric Diagnoses in Inner City Outpatients with Moderate to Severe Asthma. The International Journal of Psychiatry in Medicine. 30(4). 319–327. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026